Effect of prolonged treatment with adrenergic neuron blocking drugs on sympathoadrenal reactivity in rats

European Journal of Pharmacology
H GrobeckerI J Kopin


The effects of repeated high doses of the adrenergic neuron blocking drug guanethidine or a hexahydropyrazinoindole compound (2-guanyl-1,2,3,10,10a, hexahydro-1,2,a-pyrazinoindole, EMD 21192) (30 mg/kg i.p., 21.5 mg/kg i.p. respectively, equimolar doses) on sympathoadrenal activity were investigated in normotensive adult rats. During treatment for 5 weeks with either guanethidine or EMD 21192 the systemic blood pressure fell steadily. Noradrenaline content in the heart and vas deferens were decreased markedly by guanethidine and to a much less degree by EMD 21192. EMD 21192 markedly lowers the catecholamine content of the adrenal medulla, presumably as a result of inhibition of dopamine-beta-hydroxylase. The plasma catecholamine concentrations reflected the different sites of action of the drugs in the sympathoadrenal system, i.e. guanethidine mainly reduced circulating norepinephrine and dopamine-beta-hydroxylase by more than 50%, whereas EMD 21192 decreased considerably by the total catecholamines (mainly epinephrine) without altering significantly in the plasma norepinephrine. Disappearance or reduction of fluorescent nerve endings in the iris and the heart and a decrease of the intensity of fluorescence in chromaffin cells ...Continue Reading


Feb 1, 1975·Life Sciences·D P HenryR H Williams
May 1, 1971·The Journal of Pharmacy and Pharmacology·L MaîtreH Brunner
Jan 1, 1972·British Journal of Pharmacology·B A BerkowitzJ H Tarver
Aug 1, 1974·Journal of Neurochemistry·M Fillenz, D P West
Oct 1, 1974·European Journal of Pharmacology·S R O'Donnell, N Saar
Mar 1, 1971·Circulation Research·R Weinshilboum, J Axelrod
Apr 28, 1971·Nature: New Biology·R WeinshilboumI J Kopin
Nov 1, 1971·The Histochemical Journal·O Eränkö, L Eränkö
Jan 1, 1971·European Journal of Pharmacology·G BurnstockM L Mashford
Sep 3, 1971·Science·R Weinshilboum, J Axelrod
Jan 1, 1965·Annual Review of Pharmacology·A L BOURA, A F GREEN


Dec 24, 2004·Neurotoxicity Research·D M Jacobowitz
Nov 1, 1989·Journal of the Autonomic Nervous System·B A Barron, G R Van Loon
Jan 1, 1984·Microbiology and Immunology·J SakuraiK Endo
Oct 19, 2014·Circulation Research·Elizabeth S BarrieWolfgang Sadee
Nov 24, 1999·The American Journal of Physiology·L C NavegantesI C Kettelhut

Related Concepts

Adrenal Glands
Diastolic Blood Pressure
Guanethidine Sulfate (2: 1), 14C-Labeled
Norepinephrine, (+, -)-Isomer

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Alzheimer's Disease: MS4A

Variants within the membrane-spanning 4-domains subfamily A (MS4A) gene cluster have recently been implicated in Alzheimer's disease in genome-wide association studies. Here is the latest research on Alzheimer's disease and MS4A.

Pediculosis pubis

Pediculosis pubis is a disease caused by a parasitic insect known as Pthirus pubis, which infests human pubic hair, as well as other areas with hair including eye lashes. Here is the latest research.

Rh Isoimmunization

Rh isoimmunization is a potentially preventable condition that occasionally is associated with significant perinatal morbidity or mortality. Discover the latest research on Rh Isoimmunization here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells. It also follows CRISPR-Cas9 approaches to generating genetic mutants as a means of understanding the effect of genetics on phenotype.

Enzyme Evolution

This feed focuses on molecular models of enzyme evolution and new approaches (such as adaptive laboratory evolution) to metabolic engineering of microorganisms. Here is the latest research.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Pharmacology of Proteinopathies

This feed focuses on the pharmacology of proteinopathies - diseases in which proteins abnormally aggregate (i.e. Alzheimer’s, Parkinson’s, etc.). Discover the latest research in this field with this feed.

Alignment-free Sequence Analysis Tools

Alignment-free sequence analyses have been applied to problems ranging from whole-genome phylogeny to the classification of protein families, identification of horizontally transferred genes, and detection of recombined sequences. Here is the latest research.